Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Condition:   Charcot-Marie-Tooth Disease, Type IA Intervention:   Drug: PXT3003 Sponsors:   Pharnext SA;   SynteractHCR;   INC Research Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials